Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Search results for

There are 22,099 results that match your search.22,099 results
  • biriulin.jpg
    Russia: Trade mark sought for Kennedy’s Assassin
    Strange overtones sometimes accompany intellectual property. Usually businesses register trade marks to promote their goods. In this case a Russian company filed a trade mark application for a trade mark Kennedy's Assassin in class 41 (production and distribution of motion pictures).
    Managing IP Correspondent, September 01 2014
  • rutledge.jpg
    New Zealand: Filing of divisional applications to be restricted
    New Zealand's new Patents Act 2013 will come into force on or before September 13 2014. The main changes include tougher examination of patent applications, timing and deadlines, subject matter exclusions and divisional applications.
    Managing IP Correspondent, September 01 2014
  • wong.jpg
    Singapore: Reasons to file first in Singapore
    Where there are commercial requirements for obtaining early grant of a patent in multiple jurisdictions, filing first in Singapore can be considered as part of a global filing strategy.
    Managing IP Correspondent, September 01 2014
  • mahieu.jpg
    Belgium: Beware of the AMPI!
    Inventors and authors who seek protection of their intellectual property should be made aware of misleading practices resulting from the provision of non-official titles of IP protection.
    Managing IP Correspondent, September 01 2014
  • sonn.jpg
    Austria: Company names and trade marks
    Within the EU the attack on a trade mark on the basis of a company name is often problematic with regard to proofs both against national trade marks and EU trade marks. According to the EU Trade Marks Directive Article 4.4 (b) a member state may provide for such action. If it does this Article foresees three cumulative conditions:
    Managing IP Correspondent, September 01 2014
  • rice.jpg
    China trade marks: Revised provisions on well-known marks issued
    Following the recent amendments to the PRC Trade Mark Law that took effect on May 1 2014, China issued revised Well-Known Mark Recognition and Protection Provisions in early July 2014, with effect from August 2 2014, that supersede the existing provisions from 2003.
    Managing IP Correspondent, September 01 2014
  • jing.jpg
    China patents: New rules for patent infringement
    On July 16, China Supreme People's Court (SPC) released its amendment proposal for public comments, titled "Amendment of the Judiciary Interpretation – Certain Provisions on Issues Concerning Application of Law in Trying Cases Involving Patent Disputes". The current Judiciary Interpretation is one of the key authorities for Chinese courts to handle patent infringement cases. It has been in effect since 2001 and has had some minor changes over the years.
    Managing IP Correspondent, September 01 2014
  • beacco.jpg
    France: Supreme Court addresses generic issue
    The distinctiveness of a trade mark is appreciated from a negative point of view, that is to say the term must not be exclusively the generic or usual designation of a product.
    Managing IP Correspondent, September 01 2014
  • flow-610.jpg
    Japan: IP High Court rules in Apple v Samsung FRAND case
    In the Apple v Samsung litigation in Japan, on May 16 2014, the Grand Panel of the IP High Court affirmed the Tokyo District Court decision regarding an injunction and held that Samsung did not have a right to seek an injunction against Apple Japan regarding the patent with FRAND declaration.
    Managing IP Correspondent, September 01 2014
  • lakshmikumaran.jpg
    India: The silver lining in India’s latest CL decision
    In its recent judgment, the Bombay High Court dismissed Bayer's appeal against the grant of a compulsory license (CL) to Natco, a generic manufacturer, for its Indian patent on an anti-cancer drug called Nexavar. This order of the Bombay High Court is round three in the litigation between Bayer & Natco. The first round was before the Controller General (CG) of Patents and the second round was before the Intellectual Property Appellate Board (IPAB).
    Managing IP Correspondent, September 01 2014
Previous
1
...
971
972
973
974
975
...
2209
Next